Enteric fever, commonly known as typhoid, is a life-threatening illness caused by the Salmonella Typhi bacteria. The disease remains a significant health concern, particularly in developing countries. This article aims to provide an updated approach to managing enteric fever effectively.
Accurate diagnosis of enteric fever is critical for successful management. Blood culture remains the gold standard, but its sensitivity is limited. Recent advances include PCR and antigen detection tests, offering improved sensitivity and specificity.
Antibiotic therapy is the cornerstone of treatment. Fluoroquinolones were once the first-line treatment, but increasing resistance has necessitated a shift towards third-generation cephalosporins and azithromycin. The choice of antibiotic should be guided by local susceptibility patterns.
Vaccination plays a pivotal role in the prevention of enteric fever. Two vaccines are currently available: Vi polysaccharide vaccine and Ty21a vaccine. Both offer substantial protection and are recommended for individuals in endemic areas and travelers to these regions.
Public health measures are integral to controlling enteric fever. These include ensuring access to clean water, improving sanitation, and promoting hand hygiene. Rapid identification and treatment of cases can also help limit transmission.
Novel diagnostic tools and vaccines are under development, promising improved management of enteric fever. However, addressing the social determinants of health is crucial to achieving lasting progress.
In conclusion, the management of enteric fever requires a multifaceted approach, encompassing accurate diagnosis, appropriate antibiotic therapy, vaccination, and public health measures. Future efforts should focus on the development of novel interventions and addressing the underlying social determinants of the disease.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation